James J. Harding, MD
Gastrointestinal Medical Oncologist & Early Drug Development Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Gastrointestinal Cancers
- Liver Cancer (Hepatocellular Carcinoma)
- Bile Duct Cancers (Cholangiocarcinoma)
About Me
- Associate Attending Physician
I am a board-certified medical oncologist who specializes in caring for people with liver cancer, gallbladder cancer, and bile duct cancer, as well as other gastrointestinal cancers. My primary goal is to provide the best possible treatment and individualized care for people with these diseases. I work closely with a team of surgeons, radiation oncologists, and other medical professionals who specialize in the diagnosis and treatment of gastrointestinal cancer.
Read more
In my research, I am trying to find new, effective therapies for gastrointestinal cancer, particularly primary liver and bile duct tumors. For example, I am working on ways to use a patient’s own immune system to fight cancer, which is called immunotherapy. In addition, I am investigating strategies to block specific cellular pathways that cancer uses to grow. I have developed and am leading numerous national and international clinical trials of these new cancer therapies for patients with liver, bile duct cancers, and other solid tumors.
I am also focused on improving how we conduct clinical research with patients and increasing access to clinical trials. To this aim, I am a standing member of the Institutional Review Board, which is the committee that approves all clinical research at Memorial Sloan Kettering. I am also part of several other executive committees aimed at improving the conduct of clinical trials.
My research and training has been supported by the American Society of Clinical Oncology, the National Comprehensive Cancer Network, the National Institutes of Health, the American Association for Cancer Research, and the Howard Hughes Medical Institute. My work has been published in the New England Journal of Medicine, Nature, Nature Medicine, the Journal of Clinical Oncology, Cancer Discovery, Clinical Cancer Research, and Cancer.
A gastrointestinal (GAS-troh-in-TES-tih-nul) medical oncologist is a cancer doctor who specializes in gastrointestinal (GI) cancers. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers, as well as GI stromal tumors and neuroendocrine tumors.
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
My Specialties
- Gastrointestinal Cancers
- Liver Cancer (Hepatocellular Carcinoma)
- Bile Duct Cancers (Cholangiocarcinoma)
- Gallbladder Cancers
- Fibrolamellar Carcinoma
- Early Drug Development
- Immunotherapy
Education
- MD, Albert Einstein College of Medicine
Residencies
- Internal Medicine - NewYork-Presbyterian Hospital
Fellowships
- Oncology/Hematology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Harding sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Harding
- A Phase 1 Study of ABBV-400 in People With Advanced Solid Tumors
- A Phase 1 Study of TTI-101 in People With Advanced Liver Cancer
- A Phase 3 Study of Rilvegostomig Immunotherapy Plus Chemotherapy After Surgery for Biliary Tract Cancer
- A Phase 3 Study of Standard Treatment With and Without Zanidatamab for People With Biliary Tract Cancer
Read more
- A Phase II/III Study Comparing Chemotherapy Before and After Surgery versus After Surgery Alone to Treat Incidental Gallbladder Cancer
- Clinical Trials Co-Investigated by Dr. Harding
- A Phase 1/2 Study of FOG-001 in People With Advanced Cancer
- A Phase 1a Study of LOXO-435 in People with Advanced Solid Tumors Containing FGFR3 Gene Changes
- A Phase 1b Study of AMG 193 Plus mFOLFIRINOX or With Gemcitabine and Nab-paclitaxel in People With Advanced Pancreatic Cancer
- A Phase 2 Study of MEDI5752 and AZD2936 With Standard Treatments in People With Advanced Liver, Biliary Tract, and Gallbladder Cancers
- A Phase I Study of AGEN1811 and Balstilimab Immunotherapy in People with Fibrolamellar Carcinoma or Another Type of Gastrointestinal Cancer
- A Phase I Study of AZD1390 plus Radiation Therapy in Patients with Glioblastoma Multiforme or Brain Metastases
- A Phase II Study of Olaparib in Patients with Advanced Biliary Tract Cancer
- A Phase II Study of Trastuzumab Deruxtecan in People with HER2-Positive Solid Tumors
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Harding’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
James J. Harding discloses the following relationships and financial interests:
-
AstraZeneca
Professional Services and Activities -
Boehringer Ingelheim
Professional Services and Activities -
Bristol-Myers Squibb
Professional Services and Activities -
Cholangiocarcinoma Foundation
Professional Services and Activities -
COR2ED GmbH
Professional Services and Activities -
Creative Educational Concepts, Inc.
Professional Services and Activities -
Curio Science LLC
Professional Services and Activities -
Elevar Therapeutics
Professional Services and Activities -
Exelixis
Professional Services and Activities -
Hepion Pharmaceuticals, Inc.
Professional Services and Activities -
Jazz Pharmaceuticals
Professional Services and Activities
-
Medivir AB
Professional Services and Activities -
Merck & Co Inc.
Professional Services and Activities -
Merck Serono
Professional Services and Activities -
MJH Associates
Professional Services and Activities -
MJH Life Sciences
Professional Services and Activities -
National Comprehensive Cancer Network
Professional Services and Activities -
RayzeBio, Inc.
Professional Services and Activities -
Servier
Professional Services and Activities -
Tempus Labs, Inc.
Professional Services and Activities -
Tyra Biosciences, Inc.
Professional Services and Activities -
Zymeworks Inc.
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].